drug

PET Scan

PET scan
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
5 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

5
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
NCT05435300—Recruiting
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
NCT06278246—Active Not Recruiting
M1 Schizophrenia PET Study
NCT05105542Phase 1Completed
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
NCT02880995—Unknown
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
NCT00934635Phase 4Terminated

KOLs & investigators

4
Philip Gerretsen, MD, PhDKOL score 15
Rajiv Radhakrishnan, MDKOL score 2
Euitae Kim, Ph. D.
Ariel Graff, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Centre for Addiction and Mental Health
company
trial
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
trial
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
trial
M1 Schizophrenia PET Study
PHASE1
trial
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
NA
trial
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
PHASE4
trial
indication
Schizophrenia
indication
Healthy
indication
Schizophreniform Disorders
indication
Schizophrenia
indication
KOL
Philip Gerretsen, MD, PhD
KOL score 15
person
Rajiv Radhakrishnan, MD
KOL score 2
person
Euitae Kim, Ph. D.
KOL score —
person
Ariel Graff, MD, PhD
KOL score —
person